'Irinotecan' presentation slideshows

Irinotecan - PowerPoint PPT Presentation

Background

Background

Phase II trial of irinotecan/docetaxel for advanced pancreatic cancer with randomization between irinotecan/docetaxel and irinotecan/docetaxel plus C225, a monoclonal antibody to the epidermal growth factor receptor (EGF-r) : an Eastern Cooperative Oncology Group Study (E8200).

★ ★ ★ ★ ★

465 views • 32 slides
BICC-C Study

BICC-C Study

BICC-C Study. A Randomized, Multi-Center Phase III Trial of Irinotecan in Combination with Three Different Methods of Administration of Fluoropyrimidine with Celecoxib versus Placebo as First-line Treatment for Patients with Metastatic Colorectal Cancer

★ ★ ★ ★ ★

527 views • 28 slides
DC beads loaded with Irinotecan : precilinical in-vitro & in-vivo evaluation

DC beads loaded with Irinotecan : precilinical in-vitro & in-vivo evaluation

DC beads loaded with Irinotecan : precilinical in-vitro & in-vivo evaluation. T de Baere. Bench top Animal model. Colorectal cancer chemotherapy. % response rate. FOLFIRI. FOLFOX. LV5FU2. 5FU-FA. 55 %. 55 %. 5 FU. 25 %. 20 %. 10 %. Sytemic therapy.

★ ★ ★ ★ ★

399 views • 25 slides
Camptothecin

Camptothecin

Camptothecin. Conni Covington Seboo Dhakhwa. What is Camptothecin?. Camptothecin is an alkaloid produced by Camptotheca acuminata and Mappia foetida Irinotecan is a less toxic, more water-soluble derivative of camptothecin

★ ★ ★ ★ ★

554 views • 14 slides
COLON CANCER

COLON CANCER

COLON CANCER. A MAJOR ISSUE IN ALASKA. A common malignancy. 200,000 cases in the U. S. in 2008 Greater than 50 new cases each year in Alaska Natives . RISK FACTORS. Age Family history Genetic predisposition Adenomatous polyps History of other gastrointestinal malignancies. Screening.

★ ★ ★ ★ ★

839 views • 13 slides
Background

Background

Cetuximab Plus Irinotecan for Metastatic Colorectal Cancer (mCRC): Safety Analysis of the first 800 Patients in a Randomized Phase III Trial (EPIC): Abstract #3556. Y.A. Abubakr, C. Eng, V. Pautret, J.Maurel, W. Scheithauer, H. Kroning, A. Zubel, M.P. Lutz, L. Wong, A. Sobrero. Background.

★ ★ ★ ★ ★

191 views • 8 slides
Growing Scientific and Medical Credibility

Growing Scientific and Medical Credibility

Growing Scientific and Medical Credibility. Abstracts:. Please contact your TERUMO Sales Representative for more information. Growing Scientific and Medical Credibility. Publications:.

★ ★ ★ ★ ★

97 views • 2 slides
Table 4 Assessing the impact of dMMR on response to irinotecan

Table 4 Assessing the impact of dMMR on response to irinotecan

Table 4 Assessing the impact of dMMR on response to irinotecan. Hewish, M. et al . (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.18.

★ ★ ★ ★ ★

117 views • 1 slides

View Irinotecan PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Irinotecan PowerPoint presentations. You can view or download Irinotecan presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.